Diabetes
Diabetes(糖尿病)
Diabetes 相关产品(254)
An internal standard for the quantification of cholesterol
An internal standard for the quantification of (–)-epigallocatechin gallate
Inhibitor of glucosylceramide synthase and non-lysosomal glucosylceramidase
A peptide glucagon receptor antagonist
An internal standard for the quantification of C16 sphingomyelin
An intermediate in the metabolism of valine
A metabolite of leucine catabolism
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC40203 | Cholesterol-d6 | 60816-17-3 | >99.00% | |
An internal standard for the quantification of cholesterol | ||||
| GC40218 | (-)-Epigallocatechin Gallate-d3/d4 | - | >99.00% | |
An internal standard for the quantification of (–)-epigallocatechin gallate | ||||
| GC40317 | 10(R)-PAHSA | 2270844-02-3 | >95.00% | |
A stereoisomer of 10-PAHSA | ||||
| GC40318 | 10(S)-PAHSA | 2270843-65-5 | >95.00% | |
A stereoisomer of 10-PAHSA | ||||
| GC40320 | 12-PAHSA | 1997286-65-3 | >95.00% |  |
A FAHFA with anti-diabetic potential | ||||
| GC40323 | 9(R)-PAHSA | 2097130-84-0 | >95.00% | |
A stereoisomer of 9-PAHSA | ||||
| GC40324 | 9(S)-PAHSA | 2097130-87-3 | >95.00% | |
The S enantiomer of 9-PAHSA | ||||
| GC40325 | 9-PAHSA | 1481636-31-0 | >95.00% |  |
9-PAHSA是一种内源性生物活性脂质，属于脂肪酸类（FAHFAs）。 | ||||
| GC40636 | Amorfrutin A | 80489-90-3 | >97.00% | |
An antidiabetic natural product | ||||
| GC40889 | Benzomalvin A | 157047-96-6 | - | |
A fungal metabolite | ||||
| GC41339 | Pioglitazone Ketone | 146062-45-5 | >98.00% | |
An active metabolite of pioglitazone | ||||
| GC41406 | AMP-Deoxynojirimycin | 216758-20-2 | >95.00% | |
Inhibitor of glucosylceramide synthase and non-lysosomal glucosylceramidase | ||||
| GC41601 | CAY10591 | 839699-72-8 | >98.00% |  |
A SIRT1 activator | ||||
| GC41743 | [Des-His1,Glu9]-Glucagon (1-29) amide (trifluoroacetate salt) | - | >95.00% | |
A peptide glucagon receptor antagonist | ||||
| GC41746 | [Ser4,Ile8]-Oxytocin (trifluoroacetate salt) | - | >95.00% | |
A neuropeptide | ||||
| GC41794 | 1,2-Diheptanoyl-sn-glycero-3-PC | 39036-04-9 | >95.00% | |
A synthetic phosphatidylcholine | ||||
| GC41869 | 10-OAHSA | 2005487-34-1 | >95.00% |  |
A FAHFA with anti-diabetic potential | ||||
| GC41871 | 10-POHSA | - | >95.00% |  |
A FAHFA with anti-diabetic potential | ||||
| GC41872 | 10-SAHSA | 2320261-81-0 | >95.00% |  |
A FAHFA with anti-diabetic potential | ||||
| GC41907 | 13C C16 Sphingomyelin (d18:1/16:0) | 144236-99-7 | >98.00% | |
An internal standard for the quantification of C16 sphingomyelin | ||||
| GC42291 | 3-Hydroxyisobutyrate (sodium salt) | 1219589-99-7 | >95.00% / >96.00% | |
An intermediate in the metabolism of valine | ||||
| GC42411 | 4-hydroxy Nonenal Alkyne | 1011268-23-7 | >98.00% | |
4-HNE modified for click chemistry | ||||
| GC42434 | 4-methyl-2-Oxovalerate (sodium salt) | 4502-00-5 | >95.00% | |
A metabolite of leucine catabolism | ||||
| GC42548 | 5-hydroxy Saxagliptin (hydrochloride) | - | >95.00% | |
A major active metabolite of saxagliptin | ||||